Transitional cell carcinoma: Difference between revisions
No edit summary |
(Mahshid) |
||
| (8 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Transitional cell carcinoma}} | {{Transitional cell carcinoma}} | ||
'''For patient information page click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information page click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{SCC}} | {{SCC}};{{AE}} {{PSK}} | ||
{{SK}} Transitional cell cancer, Urothelial cancer, Urothelial cell cancer, Urothelial cell carcinoma, Urothelial carcinoma, Urothelium cancer, Urothelium carcinoma, Cancer of urothelium, Carcinoma of urothelium, Cancer of transitional cell, Carcinoma of transitional cell, TCC, UCC | |||
==[[Transitional cell carcinoma overview|Overview]]== | ==[[Transitional cell carcinoma overview|Overview]]== | ||
| Line 10: | Line 11: | ||
==[[Transitional cell carcinoma historical perspective|Historical Perspective]]== | ==[[Transitional cell carcinoma historical perspective|Historical Perspective]]== | ||
==[[Transitional cell carcinoma classification| | ==[[Transitional cell carcinoma classification|Classification]]== | ||
==[[Transitional cell carcinoma pathophysiology|Pathophysiology]]== | ==[[Transitional cell carcinoma pathophysiology|Pathophysiology]]== | ||
| Line 27: | Line 28: | ||
==Diagnosis== | ==Diagnosis== | ||
[[Transitional cell carcinoma staging|Staging]] | [[Transitional cell carcinoma history and symptoms|History and Symptoms]] | [[Transitional cell carcinoma physical examination|Physical Examination]] | [[Transitional cell carcinoma laboratory findings|Laboratory Findings]] | [[Transitional cell carcinoma cystoscopy and bladder biopsy|Cystoscopy and Bladder Biopsy | [[Transitional cell carcinoma staging|Staging]] | [[Transitional cell carcinoma history and symptoms|History and Symptoms]] | [[Transitional cell carcinoma physical examination|Physical Examination]] | [[Transitional cell carcinoma laboratory findings|Laboratory Findings]] | [[Transitional cell carcinoma cystoscopy and bladder biopsy|Cystoscopy and Bladder Biopsy]] | [[Transitional cell carcinoma CT|CT]] | [[Transitional cell carcinoma MRI|MRI]] | [[Transitional cell carcinoma ultrasound|Ultrasound]] | [[Transitional cell carcinoma other imaging findings|Other Imaging Findings]] | [[Transitional cell carcinoma other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
| Line 41: | Line 42: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
Latest revision as of 17:21, 27 November 2017
|
Transitional cell carcinoma Microchapters |
|
Differentiating Transitional cell carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Transitional cell carcinoma On the Web |
|
American Roentgen Ray Society Images of Transitional cell carcinoma |
|
Directions to Hospitals Treating Transitional cell carcinoma |
|
Risk calculators and risk factors for Transitional cell carcinoma |
For patient information page click here
Steven C. Campbell, M.D., Ph.D.;Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [1]
Synonyms and keywords: Transitional cell cancer, Urothelial cancer, Urothelial cell cancer, Urothelial cell carcinoma, Urothelial carcinoma, Urothelium cancer, Urothelium carcinoma, Cancer of urothelium, Carcinoma of urothelium, Cancer of transitional cell, Carcinoma of transitional cell, TCC, UCC
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Transitional cell carcinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | Cystoscopy and Bladder Biopsy | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies